ADDUS HOMECARE CORP (ADUS)

US0067391062 - Common Stock

120.84  -0.15 (-0.12%)

After market: 120.84 0 (0%)

Fundamental Rating

7

Taking everything into account, ADUS scores 7 out of 10 in our fundamental rating. ADUS was compared to 113 industry peers in the Health Care Providers & Services industry. ADUS gets an excellent profitability rating and is at the same time showing great financial health properties. ADUS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes ADUS very considerable for growth and quality investing!



8

1. Profitability

1.1 Basic Checks

ADUS had positive earnings in the past year.
In the past year ADUS had a positive cash flow from operations.
In the past 5 years ADUS has always been profitable.
Each year in the past 5 years ADUS had a positive operating cash flow.

1.2 Ratios

ADUS has a better Return On Assets (6.17%) than 87.61% of its industry peers.
ADUS has a Return On Equity of 7.48%. This is in the better half of the industry: ADUS outperforms 73.45% of its industry peers.
ADUS's Return On Invested Capital of 7.94% is fine compared to the rest of the industry. ADUS outperforms 79.65% of its industry peers.
ADUS had an Average Return On Invested Capital over the past 3 years of 7.41%. This is in line with the industry average of 8.10%.
The 3 year average ROIC (7.41%) for ADUS is below the current ROIC(7.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.17%
ROE 7.48%
ROIC 7.94%
ROA(3y)5.26%
ROA(5y)4.69%
ROE(3y)7.99%
ROE(5y)7.13%
ROIC(3y)7.41%
ROIC(5y)6.45%

1.3 Margins

ADUS has a better Profit Margin (6.18%) than 85.84% of its industry peers.
In the last couple of years the Profit Margin of ADUS has grown nicely.
ADUS has a Operating Margin of 9.00%. This is amongst the best in the industry. ADUS outperforms 82.30% of its industry peers.
ADUS's Operating Margin has improved in the last couple of years.
The Gross Margin of ADUS (32.27%) is better than 60.18% of its industry peers.
ADUS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) 6.18%
GM 32.27%
OM growth 3Y9.99%
OM growth 5Y14.67%
PM growth 3Y10.91%
PM growth 5Y13.22%
GM growth 3Y3.16%
GM growth 5Y4.03%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADUS is destroying value.
Compared to 1 year ago, ADUS has more shares outstanding
The number of shares outstanding for ADUS has been increased compared to 5 years ago.
ADUS has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 8.63 indicates that ADUS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.63, ADUS belongs to the best of the industry, outperforming 94.69% of the companies in the same industry.
ADUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.63
ROIC/WACC0.89
WACC8.89%

2.3 Liquidity

ADUS has a Current Ratio of 2.00. This is a normal value and indicates that ADUS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 2.00, ADUS is doing good in the industry, outperforming 71.68% of the companies in the same industry.
A Quick Ratio of 2.00 indicates that ADUS should not have too much problems paying its short term obligations.
ADUS has a better Quick ratio (2.00) than 75.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2

7

3. Growth

3.1 Past

ADUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.47%, which is quite impressive.
Measured over the past years, ADUS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.26% on average per year.
ADUS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.15%.
Measured over the past years, ADUS shows a quite strong growth in Revenue. The Revenue has been growing by 15.43% on average per year.
EPS 1Y (TTM)20.47%
EPS 3Y13.56%
EPS 5Y18.26%
EPS Q2Q%13.04%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y11.45%
Revenue growth 5Y15.43%
Sales Q2Q%7.04%

3.2 Future

The Earnings Per Share is expected to grow by 13.91% on average over the next years. This is quite good.
Based on estimates for the next years, ADUS will show a quite strong growth in Revenue. The Revenue will grow by 11.94% on average per year.
EPS Next Y18.15%
EPS Next 2Y14.7%
EPS Next 3Y13.91%
EPS Next 5YN/A
Revenue Next Year7.61%
Revenue Next 2Y12.03%
Revenue Next 3Y11.94%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

ADUS is valuated rather expensively with a Price/Earnings ratio of 23.33.
Compared to the rest of the industry, the Price/Earnings ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 68.14% of the companies listed in the same industry.
ADUS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.96, which is the current average of the S&P500 Index.
ADUS is valuated rather expensively with a Price/Forward Earnings ratio of 20.37.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ADUS indicates a somewhat cheap valuation: ADUS is cheaper than 65.49% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.82. ADUS is around the same levels.
Industry RankSector Rank
PE 23.33
Fwd PE 20.37

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ADUS is on the same level as its industry peers.
76.11% of the companies in the same industry are more expensive than ADUS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.08
EV/EBITDA 17.64

4.3 Compensation for Growth

ADUS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ADUS has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ADUS's earnings are expected to grow with 13.91% in the coming years.
PEG (NY)1.29
PEG (5Y)1.28
EPS Next 2Y14.7%
EPS Next 3Y13.91%

0

5. Dividend

5.1 Amount

ADUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ADDUS HOMECARE CORP

NASDAQ:ADUS (11/21/2024, 8:10:52 PM)

After market: 120.84 0 (0%)

120.84

-0.15 (-0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.19B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 23.33
Fwd PE 20.37
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.29
PEG (5Y)1.28
Profitability
Industry RankSector Rank
ROA 6.17%
ROE 7.48%
ROCE
ROIC
ROICexc
ROICexgc
OM 9%
PM (TTM) 6.18%
GM 32.27%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2
Quick Ratio 2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)20.47%
EPS 3Y13.56%
EPS 5Y
EPS Q2Q%
EPS Next Y18.15%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10.15%
Revenue growth 3Y11.45%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y